fbpx Skip to content

The AMD Experts

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to turn their practice into an AMD Center of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Our Blog: October 15, 2021

I Take Comfort in Greater Certainty

Dr. Glenn Corbin, one of the earliest adopters of dark adaptation testing in optometric practice, explains how using both structural and functional testing removes the guesswork out of AMD diagnosis and monitoring.

Article: October 1, 2021 | Optometric Management

Diagnose AMD Early With Protocols

Dr. Glenn Corbin believes eye care providers can diagnose AMD early by implementing protocols that make the transition from suspicion to diagnosis smooth and pleasant for patients. Here’s the protocol used in his practice.

Article: September 28, 2021 | Review of Optometric Business

The Diagnostic Protocol Change That Transformed My Practice

Dr. Claudio Lagunas purchased two AdaptDx Pro devices to keep up with demand. This technology has transformed care in his practice while spurring profitability and allowing his team to make dark adaptation testing the norm, rather than the exception.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.